Study S001679

GLIMR COPD: GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07747805
Acronym: GLIMR COPD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 30
Start: 2026-08-28
Primary completion: 2028-08-15
Lead sponsor: The Cleveland Clinic
Conditions: COPD; Obesity & Overweight; Sarcopenia
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:Mandel MAG0024

Registered primary outcomes

Change in FEV1 [12 months]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0005326	Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes. Foer D, American journal of respiratory and critical care medicine	2023	Nonrandomized study	PMID 37647574 DOI	registry reference BACKGROUND:37647574
R0007725	Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. Hong Y, Journal of cachexia, sarcopenia and muscle	2019	Preclinical	PMID 31020810 DOI	registry reference BACKGROUND:31020810